The TFX Pharma’s mission is the propagation of the idea of thymotherapy among patients and doctors as well as providing them with thymus formulations of the highest quality. TFX Pharma is the market authorization holder of TFX – immunomodulatory drug which increases generalized and local immune response, mitigates the processes of autoaggression while remaining safe to the patient.
TFX Pharma is the pioneer of Polish biotechnological innovation with over 30 years of experience in production of thymus-based formulations. TFX Pharma offers unique technology for production of formulations based on thymus glands of the highest quality imported from New Zealand. TFX Pharma represents a body of knowledge based on experience and 35 years of clinical trials conducted under the patronage of the Polish leaders in the field of thymotherapy – professors Julian Aleksandrowicz and Gabriel Turowski. We nurture the immunity of our clients, offering a formulation which holistically boosts immune response. With pride and great care, we provide you with complex protection for your organism, which proves beneficial for a growing number of our clients.